Advertisement

Topics

Dompé Farmaceutici S.p.A. Company Profile

02:09 EDT 18th June 2018 | BioPortfolio

Dompé is one of the most dynamic, flexible and innovative set-ups on the European scene.Successful in the traditional pharmaceutical market in the treatment of respiratory and osteoarticular pathologies, Dompé has also developed its presence in the area of biotechnology with innovative drugs and services
Its objective is to give value to every phase of production, every new research project, every sort of relationship with the Doctor and the Patient.
Flexibility, quality and the capacity for constructive work make Dompé the ideal partner

Location

Via San Martino, 12-12/a
Milano
20122
Italy

Contact

Phone: 39 02 583831
Fax: 39 02 58300590
Email: webmaster@dompe.it


News Articles [18 Associated News Articles listed on BioPortfolio]

NICE rejects rare eye disease drug

Cost regulators for NHS therapies in England and Wales have published draft guidelines rejecting funding for Dompé’s cenegermin as a treatment for neurotrophic keratitis, a rare eye condition.

NICE rejects rare eye disease therapy

NICE has rejected a treatment for a rare eye disorder, a first draft decision ruling Dompé's drug too expensive for the NHS. This decision would leave some patients facing the only option of a chea...

MA granted for drug tested in just 34 patients

An absence of comprehensive data did not prevent Italian family-owned drugmaker Chiesi Farmaceutici from…

Pending EC decision: CHF 5993 Chiesi Farmaceutici S.p.A., beclometasone dipropionate anhydrous / formoterol fumarate dihydrate / glycopyrronium, Opinion date: 22-Feb-2018

Human medicines European public assessment report (EPAR): Riarify (previously CHF 5993 Chiesi Farmaceutici S.p.A.), beclometasone / formoterol / glycopyrronium bromide, Revision: 0, Authorised

Excelencia farmacéutica italiana en I+D durante el 33rd Congress of the European Association ...

     (Logo: https://mma.prnewswire.com/media/655337/Fidia_Farmceutici_Logo.jpg) Fidia Farmaceutici anunció hoy los resultados positivos de un ensayo en fase II en el que se evalúa la efica...

Pharmazeutische F&E-Spitzenleistung aus Italien beim 33. ...

     (Logo: https://mma.prnewswire.com/media/655337/Fidia_Farmceutici_Logo.jpg) Fidia Farmaceutici gab heute die positiven Ergebnisse einer Phase-II-Studie bekannt, in der Wirksamkeit und Vertr...

Excellence italienne en RD pharmaceutique au 33ème Congrès de l'Association européenne d'urologie

     (Logo: https://mma.prnewswire.com/media/655337/Fidia_Farmceutici_Logo.jpg) Fidia Farmaceutici a annoncé aujourd'hui les résultats positifs d'un essai de phase II évaluant l'efficacit...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Curosurf [Cornerstone Therapeutics Inc.]

CUROSURF (poractant alfa)Intratracheal Suspension

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Effect of the concentration of circulating prolactin on dairy cows' responsiveness to domperidone injection.

The objective of this study was to determine whether the responsiveness of the mammary gland to prolactin (PRL) is affected by the concentration of the hormone. After 1 pre-experimental week (d -7 t...

Triticum vulgare extract exerts an anti-inflammatory action in two in vitro models of inflammation in microglial cells.

Triticum vulgare has been extensively used in traditional medicine thanks to its properties of accelerating tissue repair. The specific extract of Triticum vulgare manufactured by Farmaceutici Damor (...

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Filler Performance on the Nasolabial Folds of Aliaxin® EV With and Without Lidocaine 0.3%

Evaluation of the filler performance on the nasolabial folds of Aliaxin® EV with and without lidocaine 0.3%: comparison within subjects (half face method)

Evaluation of the Re-volumizing Performance of Aliaxin (New Trademark)

Aim of the study is to evaluate the re-volumizing performance and the duration effect of the product Aliaxin (new trademark) in women aged 40-65 years with midface volume defects due to ag...

Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma

The purpose of this trial is to verify if the test treatment BDP 250 mcg/salbutamol 100 mcg HFA pMDI fixed combination is non-inferior to BDP 250 mcg/salbutamol 100 mcg pMDI fixed combina...

Early Viscosupplementation After Partial Meniscectomy: a Randomized Controlled Trial

The rational of intra-articular viscosupplementation is based on both the biological and mechanical properties of HA, which exerts positive effects on the modulation of the entire joint en...

Companies [6 Associated Companies listed on BioPortfolio]

Dompé Farmaceutici S.p.A.

Dompé is one of the most dynamic, flexible and innovative set-ups on the European scene.Successful in the traditional pharmaceutical market in the treatment of respiratory and osteoarticular patholog...

Fidia Farmaceutici

Fidia Farmaceutici is part of Fidia Pharma Group, an Italian multinational company, with R&D, manufacturing and sales capabilities, and an extensive product portfolio mainly based...

ViRexx Medical

ViRexx Medical Corp. is an Edmonton, Alberta based biotechnology company focused on the development of novel therapeutic products for the treatment of cancer and chronic viral infections. ViRexx's mos...

Chiesi Farmaceutici S.p.A.

Chiesi Pharmaceuticals, which started up in 1935 as a small family company is today an international company in the pharmaceutical sector and operates in all 5 continents with 24 direct branches, 3 ...

Mediolanum farmaceutici S.p.A

Nil

More Information about "Dompé Farmaceutici S.p.A." on BioPortfolio

We have published hundreds of Dompé Farmaceutici S.p.A. news stories on BioPortfolio along with dozens of Dompé Farmaceutici S.p.A. Clinical Trials and PubMed Articles about Dompé Farmaceutici S.p.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dompé Farmaceutici S.p.A. Companies in our database. You can also find out about relevant Dompé Farmaceutici S.p.A. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record